Synthesis, inhibition properties and theoretical study of the new nanomolar trehalase inhibitor 1-thiatrehazolin: Towards a structural understanding of trehazolin inhibition by Chiara, José Luis et al.
Synthesis, inhibition properties and theoretical study of the new 
nanomolar trehalase inhibitor 1-thiatrehazolin: Towards a structural 
understanding of trehazolin inhibition 
 
Jose Luis Chiara,*[a] Isabel Storch de Gracia, [a] Ángela García, [a] Ágatha Bastida, [a] 
Sofía Bobo, [a] and María D. Martín-Ortega[a] 
 
 
[a] Dr. J. L. Chiara, Dr.  I. Storch de Gracia, A. García, Dr. A. Bastida, S. Bobo, M. D. 
Martín-Ortega. 
Instituto de Química Orgánica General, CSIC, Juan de la Cierva, 3. E-28006 Madrid. 
Spain. Fax: 34 915644853; E-mail: jl.chiara@iqog.csic.es 
 
 
 
1 
Abstract 
A new trehazolin analogue, 1-thiatrehazolin, has been synthesized from 
carbohydrate precursors by a highly efficient route based on our previously developed 
ketone/oxime ether reductive carbocyclization reaction for the construction of the 
cyclitol ring and an intramolecular nucleophilic displacement reaction for the 
construction of the thiazoline ring. 1-Thiatrehazolin is a very potent, slow, tight-binding 
trehalase inhibitor. On the basis of the experimental results, a structural model for 
trehalase inhibition by trehazolin and analogues is proposed, supported by theoretical 
calculations. 
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2 
Introduction 
α,α-Trehalose (1) is a non-reducing disaccharide formed by two molecules of D-glucose 
α,α-1,1-linked that is widespread throughout a large variety of organisms including 
bacteria, yeast, fungi, insects, nematodes, and plants. In bacteria, fungi, insects, and 
nematodes it serves as source of energy and carbon, while in yeast and plants it may 
also have a signaling function.[1] In addition, trehalose has been shown to play a 
protecting role against different stress conditions. Trehalase (EC 3.2.1.28) is a very 
specific enzyme that hydrolyzes trehalose to two glucose units, an essential process in 
the life functions of various organisms, in particular fungi, insects and nematodes. 
Accordingly, trehalase inhibitors are of potential interest for crop protection. Several 
trehalase inhibitors have been isolated from natural sources, including deoxynojirimycin 
(2),[2] validamycins (3),[3] validoxylamines (4),[4] trehazolin (5),[5] salbostatin (6),[6] and 
calystegin B4 (7).[7] Among these natural inhibitors, trehazolin is the most potent and 
specific. It has a unique pseudodisaccharide structure consisting of an α-D-
glucopyranose moiety bonded to an aminocyclopentitol (trehazolamine, 8) through a 
fused 2-aminooxazoline ring. The chemistry and biochemistry of 5 has been thoroughly 
investigated.[8, 9] Inhibition of trehalases by trehazolin is of the reversible, competitive 
type with respect to trehalose.[10, 11] Trehalases are inverting glycosidases, which implies 
the presence in the active site of the enzyme of a catalytic acid group together with a 
nucleophilic water molecule.[12] Kinetic studies performed with porcine kidney trehalase 
in the presence of two types of competitive inhibitors[13] support the earlier 
hypothesis[14] that the active center of the enzyme may comprise two subsites, one for 
catalysis and one for recognition, acting separately on each glucose unit of trehalose. 
This conclusion could probably be extended to other trehalases. Although there is no 
structural information available yet on any enzyme-inhibitor complex for 5, the cyclitol 
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moiety seems to mimic the transition state leading to the high-energy glucopyranosyl 
intermediate involved in the enzymatic hydrolysis reaction. It has been proposed[8] that 
the anomeric nitrogen of 5 interacts with the catalytic acid group while the nitrogen or 
the oxygen atom of the oxazoline ring acts as a surrogate for the nucleophilic water 
molecule. Extensive structure-activity relationship studies have shown that the 
inhibitory potency is highly sensitive to subtle structural modifications at the pyranose 
or cyclopentitol moieties.[8] Only the 5a’-carba-analogue 9[15] conserves the nanomolar 
inhibitory activity of the parent compound against trehalases as well as a higher 
chemical stability. Very little is known, however, about the effect of structural 
modifications at the oxazoline ring. The only analogue of this type described is 
compound 10[16] that contains an imidazoline ring, but also two other concomitant 
structural modifications: a 5a-carbaglucose to confer stability towards hydrolytic 
cleavage without compromising activity, and a 4-de(hydroxymethyl) cyclitol moiety, a 
modification that has been shown[17] to lower the inhibitory activity by 100-times with 
respect to parent 5. Since compound 10 is 1000-times less potent than trehazolin against 
silkworm trehalase, it can be concluded from the above that the oxazoline to 
imidazoline modification is clearly deleterious to inhibitory activity by roughly an order 
of magnitude. With this knowledge in mind, we decided to prepare the corresponding 
thiazoline analogue 11 and assay its inhibitory activity against trehalase.   
 
Results 
Synthesis of 11: For the preparation of 11, we relied on earlier synthetic work 
developed by our group en route to 5. We have previously described two different 
synthetic approaches to 5 from readily available carbohydrate precursors based on a 
reductive carbocyclization reaction promoted by samarium diiodide as a key step. In the 
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first approach,[18] a highly efficient two-step, one-pot oxidation-reductive coupling 
sequence[19] served to transform the 1,5-diol 12, derived from D-glucose, to a 1:1 
mixture of carbocyclic cis-diols 13 from which trehazolamine (8) and then the final 
target 5 were readily prepared by simple synthetic manipulations (Scheme 1a). A 
second and more efficient route[20] (Scheme 1b) was developed later utilizing a 
carbonyl-oxime ether reductive carbocyclization with subsequent N-O reductive 
cleavage, a highly efficient one-pot sequence that was first described by our group in 
1995.[21] Thus, treatment of keto-oxime 14, readily available from D-mannose,[20] with 
an excess of samarium diiodide (>4 equiv) promoted a very high yielding tandem 
process that consisted of a completely stereoselective reductive carbocyclization 
followed by the in situ N-O reductive cleavage of the resultant carbocyclic 
hydroxylamine, triggered upon addition of water to the reaction mixture containing 
excess SmI2. Subsequent addition of LiOH produced the in situ hydrolysis of the ester 
group to afford aminocyclopentitol 15 as a single diastereoisomer in an almost 
quantitative overall yield.[20] The high efficiency and complete diastereoselectivity of 
this tandem process is very remarkable and underscores the utility and mildness of 
samarium diiodide to promote selective transformations on highly functionalized 
substrates. The synthesis of 5 was completed via an intermediate urea derivative of 15 
from which the oxazoline ring was constructed through an intramolecular SN2 reaction 
that served also to adjust the final stereochemistry of the carbocycle. 
Thiazoline analogue 11 was readily prepared from aminocyclopentitol 15[20] as 
follows (Scheme 2). Reaction of 15 with α-D-glucosyl isothiocyanate 16[22] afforded 
thiourea 17[20] in an almost quantitative yield. Treatment of 17 with triflic anhydride and 
pyridine under our previously optimized conditions[20] produced a smooth cyclization to 
the 2-aminothiazoline 18 in very good yield with concomitant inversion of 
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stereochemistry at the center supporting the secondary hydroxyl group via 
intramolecular SN2 displacement of a transient triflate by the vicinal thiocarbonyl group. 
Complete deprotection of 18 afforded finally our target 1-thiatrehazolin 11. 
 
Enzymatic studies: Analogue 11 was tested as inhibitor against commercially available 
porcine kidney trehalase and its activity was compared to that of synthetic 5[20] 
measured under identical experimental conditions (Table 1). Compound 11 is a 
nanomolar inhibitor of this enzyme, although with an IC50 value ca. 5-fold higher than 
that of parent 5. Like 5,[10] 11 presents also a slow inhibition onset, its activity 
increasing upon preincubation with the enzyme (see Table 1). Slow binding is a 
widespread phenomenon among potent enzyme inhibitors, the inhibition process 
occurring over a period of minutes and not at diffusion-controlled rates.[23] In the case of 
11 inhibition reaches a maximum within 30 min, while potentiation proceeds up to 6 h 
in the case of 5.[10] In order to test the reversibility of the inhibition, trehalase 
preincubated with 11 at 37 ºC for 30 min was dialyzed at 4 ºC against sodium citrate/ 
Na2HPO4 buffer (pH 6.2). Dialysis gradually recovered trehalase activity, the 
percentage of regained activity with respect to a control experiment without inhibitor 
being 65% and 100% after 3 h and 18 h, respectively. Recovery has been reported to 
proceed much slower in the case of 5,[10] taking 48 h of dialysis at 4 ºC to recover only 
24% of the initial activity observed without inhibitor. Lineweaver-Burk plots (Figure 2) 
show that, as reported for natural 5,[11] 11 inhibits porcine trehalase competitively with 
respect to trehalose. From Dixon plots, Ki values were obtained for 11 and for synthetic 
5 (Table 1).  
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Discussion 
According to our kinetic studies, 1-thiatrehazolin (11) can be classified as a 
slow, tight-binding, competitive trehalase inhibitor, similar to its parent compound 5. 
This kind of inhibition is usually indicative of (reversible) covalent attachment of the 
inhibitor to the enzyme or of a conformational transition of the enzyme between two 
states that bind the inhibitor with different affinities,[23, 24] although recent studies 
indicate that could also be a consequence of relatively slow on and off binding rates 
between enzyme and inhibitor.[25] The aminooxazo(thiazo)line moiety is a potential 
electrophilic locus (at C-2) for covalent attachment of an active site nucleophile. 
However, kinetic studies with silkworm trehalase seem to rule out such a possibility for 
5.[10] Our observation that analogue 11 is also a slow, tight-binding inhibitor supports 
this conclusion since the introduction of the isosteric –S– group is expected to result in a 
substantial reduction of the net positive charge at C-2 (see below), lessening its 
electrophilic character significantly.[26] The 2-aminooxazo(thiazo)line moiety is 
however perfectly suited to form a bidentate complex with the active site carboxylic 
acid, as shown in Figure 3 (or a salt bridge after net proton transfer from the catalytic 
acid to the heterocycle). Such a complex is expected to be stronger for 5 than for its 
thiazoline analogue 11, as shown by DFT B3LYP/6-311+G(d,p) quantum mechanical 
calculations performed on a simple model for this interaction in gas phase. In this 
theoretical study, we have used acetic acid to represent the enzyme catalytic acid group 
and 2-(methylamino)oxazoline or -thiazoline as a model of 5 or 11, respectively. For the 
theoretical study, we have considered only the 2-(methylamino)-tautomer of the 
heterocycles since previous calculations[26, 27] at various levels of theory have shown 
that 2-aminooxazo(thiazo)line is more stable than the alternative 2-
iminooxazo(thiazo)lidine tautomer by ca. 2 kcal/mol. To simplify the analysis, we have 
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neglected the Z/E isomerization of the methylamino group and only the Z-isomer has 
been included in the calculations. The optimized geometry of the complexes at this level 
of theory show that 2-(methylamino)oxazoline forms a tighter complex with acetic acid 
than 2-(methylamino)thiazoline, as revealed by the smaller d1 + d2 sum of H-bond 
distances calculated for the former (Table 2). Accordingly, the enthalpies, free energies, 
and equilibrium constants calculated for the complexation reaction in the gas phase 
reveal that the oxazoline derivative forms the most stable complex (Table 2). No net 
proton transfer from acetic acid to the heterocycle with formation of a salt bridge is 
predicted at this level of theory in gas phase. Our theoretical results for this model 
interaction parallel the experimental pKa values measured for 5 and 11 (see Table 1) and 
those reported[28] for 2-aminooxazoline (pKa = 9.37) and 2-aminothiazoline (pKa = 
8.70). The equilibrium constant, Kd, calculated for the dissociation of the oxazoline 
complex in gas phase is about an order of magnitude lower than that of the thiazoline 
complex (see Table 2), in close parallel to the corresponding Ki values measured for 5 
and its thioanalogue 11. This is what could be expected if this single interaction were 
the main energy component responsible for the difference between the complexation 
reactions of each inhibitor with trehalase. Recent studies[29] on the trehalase inhibitory 
activity of a series of simple 2-(arylamino)oxazoline and –thiazoline derivatives have 
shown that the oxazoline compounds have IC50 values that are approximately an order 
of magnitude lower than their corresponding thiazoline analogues, as we have observed 
for 5 and 11, a result that can also be explained on the basis of our complexation model. 
In favor of this model is also the observation that the oxazoline to imidazoline 
modification has a deleterious effect on inhibition, as seen for analogue 10.[16] A 2-
aminoimidazoline analogue is expected to have a higher pKa value than 5 and hence be 
fully protonated at the pH of the enzyme assay and therefore would not be able to 
8 
interact efficiently with the catalytic acid group. The observation by Ando[10]  that 
trehazolin is a slightly worse inhibitor of silkworm trehalase at lower pH (IC50 = 27 nM 
at pH 6.2; IC50 = 52 nM at pH 5.4) supports also our proposal that the neutral molecule 
is the active form of the inhibitor.  
For a more in-depth understanding of the possible differential binding 
interactions of inhibitors 5 and 11 with trehalase, we have also compared the calculated 
atomic charge distributions of the two model heterocycles. NBO population analysis[30] 
show two major differences in the electronic charge distribution of the iso(thio)urea 
region of 2-(methylamino)oxazoline and 2-(methylamino)thiazoline (Table 3). First, as 
advanced above, the C-2 atom carries a lower positive charge in the thioderivative. 
Second, while the oxygen atom is highly negatively charged, the electropositive sulfur 
atom carries a positive charge. The fact that inhibition of trehalase is only slightly 
affected by changing X from oxygen to sulfur, in spite of their very different atomic 
charges and Van der Waals radii, supports the conclusion that X is probably not directly 
involved in significant interactions with residues of the catalytic site of the enzyme.  
 
Conclusion 
In summary, we have synthesized a new trehazolin analogue, 1-thiatrehazolin, 
by a very efficient route that features a highly stereoselective reductive tandem process 
promoted by samarium diiodide for the construction of the cyclitol moiety and a mild 
and high yielding intramolecular nucleophilic displacement reaction for the construction 
of the thiazoline ring. 1-Thiatrehazolin is a nanomolar, slow, tight-binding inhibitor of 
porcine trehalase. On the basis of our experimental results and those reported in the 
literature for related compounds, a structural model for the inhibition of trehalase by 
trehazolin and its analogues has been proposed, supported by theoretical calculations.  
9 
 Experimental Section 
Thiourea 17. To a solution of 15 (121 mg, 0.39 mmol) in THF (6 mL) was added 
dropwise a solution of 16[22] (227 mg, 0.39 mmol) in THF (4 mL). After stirring for 4 h 
at 30 ºC, the solvent was removed at reduced pressure and the crude was purified by 
flash chromatography (EtOAc/hexane 1:2) to afford 17 (334 mg, 96%) as a white solid. 
Rf = 0.42 (EtOAc/hexane 1:1); m.p. 81-82 ºC. [α]D22 +149.1 (c 0.9, CHCl3); IR (KBr) 
3400, 3000, 1545, 1370, 1080, 700 cm-1; 1H NMR (300 MHz, CDCl3, 25ºC, TMS) δ 
7.48 (d, 3J(H,H) = 6.0 Hz, 1 H), 7.40-7.23 (m, 22 H), 7.14-7.11 (m, 2 H), 6.65 (d, 
3J(H,H) = 1.6 Hz, 1 H), 5.17 (dd, 3J(H,H) = 4.8, 1.7 Hz, 1 H), 5.08 (s, 1H), 4.90 (d, 
3J(H,H) = 11.0 Hz, 1 H), 4.85-4.77 (m, 3 H), 4.64 (s, 2 H), 4.58 (d, 3J(H,H) = 11.6 Hz, 1 
H), 4.58 (d, 3J(H,H) = 11.6 Hz, 1 H), 4.53 (dd, 3J(H,H) = 9.9, 6.0 Hz, 1 H), 4.45 (d, 
3J(H,H) = 11.6 Hz, 1 H), 4.45 (d, 3J(H,H) = 11.6 Hz, 1 H), 4.16 (td, 3J(H,H) = 10.4, 4.4 
Hz, 1 H), 4.03 (s, 1 H), 3.85-3.67 (m, 4 H), 3.66 (s, 2 H), 3.58 (dd, 3J(H,H) = 10.4, 1.9 
Hz, 1 H), 3.53-3.44 (m, 2 H), 2.67 (d, 3J(H,H) = 10.7 Hz, 1 H), 1.70 (s, 1 H), 1.41 (s, 3 
H), 1.22 (s, 3 H); 13C NMR (75 MHz, CDCl3, 25ºC, TMS) δ 186.0, 138.1, 137.7, 137.3, 
137.2, 136.7, 128.6-127.7 (25C), 99.3, 81.7, 81.3, 79.8, 77.5, 77.3, 77.0, 76.4, 76.1, 
75.9, 75.0, 73.4, 72.3, 72.1, 71.0, 70.8, 68.2, 64.5, 26.3, 22.3; elemental analysis calcd 
for C51H58N2O10S: C, 68.74; H, 6.56; N, 3.14; S, 3.60; found: C, 68.71; H, 6.80; N, 
3.41; S, 3.52. 
Aminothiazoline 18.  To a solution of 17 (100 mg, 0.11 mmol) in CH2Cl2 (3 mL) at –
40 ºC was added pyridine (37 μL, 0.46 mmol) and triflic anhydride (25 μL, 0.15 mmol). 
After stirring at this temperature for 1 h, the mixture was diluted with CH2Cl2 (5 mL) 
and aqueous saturated NaHCO3 was added. The phases were separated and the aqueous 
phase was extracted with CH2Cl2 (3x5 mL). The combined organic extracts were 
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washed with brine, dried over Na2SO4, filtered and concentrated at reduced pressure. 
The crude was purified by flash chromatography (EtOAc/hexane 1:1) to afford 18 (91 
mg, 93%) as a colorless oil. Rf = 0.18 (EtOAc/hexane 1:1); [α]D22 +95.3 (c 2.2, CHCl3); 
1H NMR (300 MHz, CDCl3, 25ºC, TMS) δ 7.35-7.23 (m, 23 H), 7.15-7.10 (m, 2 H), 
5.35 (m, 1 H), 4.90 (d, 3J(H,H) = 10.8 Hz, 1 H), 4.80 (d, 3J(H,H) = 11.0 Hz, 1 H), 4.77 
(d, 3J(H,H) = 11.0 Hz, 1 H), 4.73 (d, 3J(H,H) = 8.7 Hz, 1 H), 4.63 (d, 3J(H,H) = 12.1 
Hz, 1 H), 4.59-4.41 (m, 7 H), 4.25 (dd, 3J(H,H) = 8.4, 3.7 Hz, 1 H), 4.19 (d, 3J(H,H) = 
12.1 Hz, 1 H), 4.04-3.99 (m, 2 H), 3.82-3.62 (m, 6 H), 1.42 (s, 3 H), 1.27 (s, 3 H); 13C 
NMR (75 MHz, CDCl3, 25ºC, TMS) δ 159.1, 138.6, 138.4, 138.1, 137.4 (2C), 128.5-
127.6 (25C), 99.0, 92.3, 85.3, 82.1 (2C), 80.4, 78.4 (2C), 77.3, 75.6, 74.9, 73.4, 72.7, 
72.4, 70.3, 68.4, 65.1, 56.7, 26.8, 21.6; elemental analysis calcd for C51H56N2O9S: C, 
70.16; H, 6.47; N, 3.21; S, 3.67; found: C, 69.98; H, 6.61; N, 3.14; S, 3.51. 
Aminothiazoline 19. To a solution of 18 (96 mg, 0.12 mmol) in MeOH/CH2Cl2 (1:1, 8 
mL) was added p-TsOH (24 mg, 0.16 mmol). After stirring at rt for 12 h,  the mixture 
was diluted with CH2Cl2 (15 mL) and aqueous saturated NaHCO3 was added. The 
phases were separated and the aqueous phase was extracted with CH2Cl2 (3x15 mL). 
The combined organic extracts were washed with brine, dried over Na2SO4, filtered and 
concentrated at reduced pressure. The crude was purified by flash chromatography 
(EtOAc/hexane 5:1) to afford 19 (81 mg, 89%) as a colourless oil. Rf = 0.37 (EtOAc); 
[α]D22 + 83.6 ( c 1.0, CHCl3); 1H NMR (300 MHz, CDCl3, 25ºC, TMS) δ 7.36-7.12 (m, 
25 H), 5.24 (d, 3J(H,H) = 4.1 Hz, 1 H), 4.90 (d, 3J(H,H) = 10.9 Hz, 1 H), 4.79 (d, 
3J(H,H) = 11.0 Hz, 1 H), 4.75 (d, 3J(H,H) = 10.2 Hz, 1 H), 4.66-4.57 (m, 5 H) , 4.50 (d, 
3J(H,H) = 9.4 Hz, 1 H), 4.46 (d, 3J(H,H) = 11.7 Hz, 1 H), 4.14 (d, 3J(H,H) = 7.2 Hz, 1 
H), 4.02 (dd, 3J(H,H) = 10.4, 5.7 Hz, 1 H), 3.85-3.62 (m, 9 H).; 13C NMR (75 MHz, 
CDCl3, 25ºC, TMS) δ 162.8, 138.6, 138.2, 138.0, 137.7, 137.3, 128.4- 127.5 (25C), 
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90.4, 82.2, 81.8, 81.0, 80.5, 80.3, 78.3, 77.3, 75.5, 74.9, 73.4, 72.7, 72.4, 70.4, 68.5, 
64.0, 52.9. 
1-Thiatrehazolin (11). A solution of 19 (98 mg, 0.12 mmol) in THF (8 mL) was added 
to a solution of Na (228 mg, 9.91 mmol) in NH3 (20 mL) at –78 ºC. The reaction 
mixture was stirred at –78 ºC to –35 ºC for 12 h, NH4Cl (263 mg) was added and the 
mixture was allowed to warm to rt. The mixture was partitioned between water (10 mL) 
and CH2Cl2 (25 mL), the aqueous phase was washed with CH2Cl2 (2x5 mL) and the 
water was removed at reduced pressure. The residue was purified by ion-exchange 
chromatography on Dowex 50W-H+ eluting with 1M NH4OH to afford 11 (45 mg, 
100%) as a white solid after liophylization. Rf = 0.40 (CH3CN/AcOH/H2O 6:1:3); [α]D22 
+ 107.2 ( c 0.7, CH3OH); IR (KBr) 3434, 1629, 1033 cm-1; 1H NMR (400 MHz, D2O, 
25ºC, TMS) δ 5.44 (d, 3J(H,H) = 5.2 Hz, 1 H), 4.66 (d, 3J(H,H) = 8.4 Hz, 1 H), 4.12-
4.05 (m, 2 H), 3.92-3.89 (m, 1 H), 3.85-3.61 (m, 6 H), 3.57-3.52 (m, 1 H), 3.40 (t, 
3J(H,H) = 9.3 Hz, 1 H); 13C NMR (100 MHz, D2O, 25ºC, TMS) δ 161.9, 83.5, 82.5, 
81.5, 81.3, 81.2, 73.2, 72.3, 70.0, 69.6, 62.8, 60.7, 54.4; MS (FAB): m/z (%): 383 (100) 
[M + H]+. 
Enzyme assays: α,α-Trehalase (EC 3.2.1.28) from porcine kidney was purchased from 
Sigma (0.7 U/mg). The reaction (45 μL total volume) was started by adding 5 μL of 
enzyme (0.7 mU) to 20 mM sodium citrate-40 mM Na2HPO4 buffer (1:1, pH 6.2) 
containing 0.2 mg/mL of bovine serum albumin, α,α-trehalose (4, 3, 2, and 1 mM), and 
various concentrations of the inhibitor (1-thiatrehazolin: 0, 7, 12,  and 25 nM; 
trehazolin: 0, 0.5, 2.5, and 5 nM). After incubation of the mixture at 37 ºC for 40 min, 
the reaction was stopped by placing the mixture on boiling water for 3 minutes. The 
reaction mixture was then cooled on ice-water, and denatured protein was removed by 
centrifugation at 12000 rpm for 5 min. Concentration of D-glucose in the supernatant 
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was determined by the glucose oxidase-peroxidase method (Glucose Trinder 100, from 
Sigma).[31] Linewaver-Burk analysis of the kinetic data afforded Km = 3.7 nM, Vmax = 
2.8 mmol/min for the enzymatic hydrolysis of trehalose without inhibitor and Km = 10.1 
nM, Vmax = 4.8 mmol/min in the presence of 11. 
 For the dialysis experiments, the enzyme and 1-thiatrehazolin (at two 
concentrations: 3.5 and 7 nM) were preincubated at 37 ºC for 30 min. The reaction 
mixture was then dialyzed against sodium citrate-Na2HPO4 buffer (pH 6.2) at 4 ºC. 
Trehalase activity was determined as above after 3 h and 18 h of dialysis. 
 
Theoretical calculations: Ab initio calculations were carried out using the Gaussian 
98[32] program package at the density functional (B3LYP) level of theory using the 6-
311+G(d,p) standard basis set. After geometry optimization, analytical frequency 
calculations were carried out to determine the nature of the stationary points found and 
to obtain thermochemical properties using standard procedures. 
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Table 1. Inhibitory activity against porcine 
trehalase (measured at 37 ºC at pH 6.2) and pKa 
values measured for synthetic 5 and 11. 
Compound IC50 (nM)[a] Ki (nM) pKa[b]
15.5[c] (5.1) 2.1[d] 6.3[e]5 
11 83.0 (20.0) 30.4 5.8 
[a] In  brackets, the value measured after 30 min 
of preincubation of the inhibitor with the 
enzyme at 37 ºC. [b] Measured by 1H NMR 
titration in D2O at 25 ºC. [c] Reported for 
natural 5 against porcine trehalase: IC50 = 16 nM 
(ref. 10); 19 nM (ref. 11). [d] Reported for 
natural 5 against silkworm trehalase: Ki = 10 nM 
(ref. 10). [e] Ref. 5b. 
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 Table 2. Computed hydrogen-bond distances, energies, enthalpies, free energies and 
dissociation equilibrium constants for the model complexation reaction of acetic acid 
with 2-(methylamino)oxazoline and 2-(methylamino)thiazoline at the B3LYP/6-
311+G(d,p) level in gas phase (at 298.15 K). 
N
XN
H
H
H
HH
H
H
H
O
O
H
H
H
HN
XN
H
H
H
HH
H
H
H
O
O
H
H
H
H
+
d1
d2
ΔE12
3
6
 
[b]X d1 (Å) d2 (Å) ΔE[a] KΔHº (kcal/mol) ΔGº (kcal/mol)  (kcal/mol) d
O 1.882 1.628 -17.45 -16.38 -6.00 3.97·10-5
S 1.876 1.651 -16.59 -15.52 -4.92 2.46·10-4
 
[a] At 0 K. [b] The equilibrium constant for the dissociation process was computed from 
the -ΔGº values (reverse reaction) using the equation: Kd = exp[-(-ΔGº)/RT]. 
 
 
Table 3. B3LYP/6-311+G(d,p) natural atomic charges calculated for 2-
(methylamino)oxazoline (X = O) and 2-(methylamino)thiazoline (X = S) (for atom 
numbering, see Table 2). 
X X-1 C-2 N-3 N-6 
O -0.574 0.727 -0.596 -0.641 
S 0.163 0.328 -0.564 -0.643 
 
 
18 
Figure legends 
 
Figure 2. Lineweaver-Burk plots of commercial pig kidney trehalase activities in the 
presence of 11. Concentrations of 11 were 0 μM (●), 7 μM (○), 12 μM (?), and 25 μM 
(?). 
 
 
Figure 3. Proposed model for the complex of inhibitors 5 (X = O) and 11 (X = S) with 
trehalase. 
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Figure 1 
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Scheme 1 
 
OH
BnO
BnO
OBn
OH
BnO
1) Swern [O]
2) SmI2, t-BuOH, -50 ºC
BnO
BnO
OBn
OH
OH
BnO
BnO
BnO
OBn
OH
OH
BnO
+
13 (1:1)
D-Glucose
O
BnO OAc
N
1) SmI2, t-BuOH, -30 ºC
BnO
NH2
D-Mannose
O
O
OBn
2) H2O; 3) LiOH
O
O
OH
OH
90%
(two-step, one-pot)
5
98%
(three-step, one-pot)
12
(a) Ref. 18
(b) Ref. 20
14 15  
 
 
 
 
 
Scheme 2 
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(Suggestion for the TOC) 
 
 
 
 
 
 
 
Ab initio model calculations of the bidentate interaction shown correctly predict the 
difference in inhibition properties of trehazolin (5) and its new and potent analogue 11 
against trehalase. 
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